4.8 Review

Dissecting and rebuilding the glioblastoma microenvironment with engineered materials

期刊

NATURE REVIEWS MATERIALS
卷 4, 期 10, 页码 651-668

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/s41578-019-0135-y

关键词

-

资金

  1. National Science Foundation
  2. National Institutes of Health (Ruth L. Kirschstein Predoctoral Individual National Research Service Award) [F31CA228317]
  3. National Institutes of Health (Ruth L. Kirschstein Postdoctoral Individual National Research Service Award) [F32CA221366, R21EB025017, R01GM122375, R01DK118940, R01CA227136]
  4. European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant [752097]
  5. Marie Curie Actions (MSCA) [752097] Funding Source: Marie Curie Actions (MSCA)

向作者/读者索取更多资源

Glioblastoma (GBM) is the most aggressive and common form of primary brain cancer. Several decades of research have provided great insight into GBM progression; however, the prognosis remains poor, with a median patient survival time of similar to 15 months. The tumour microenvironment (TME) of GBM plays a crucial role in mediating tumour progression and thus is being explored as a therapeutic target. Progress in the development of treatments targeting the TME is currently limited by a lack of model systems that can accurately recreate the distinct extracellular matrix composition and anatomic features of the brain, such as the blood-brain barrier and axonal tracts. Biomaterials can be applied to develop synthetic models of the GBM TME to mimic physiological and pathophysiological features of the brain, including cellular and extracellular matrix composition, mechanical properties and topography. In this Review, we summarize key features of the GBM microenvironment and discuss different strategies for the engineering of GBM TME models, including 2D and 3D models featuring chemical and mechanical gradients, interfaces and fluid flow. Finally, we highlight the potential of engineered TME models as platforms for mechanistic discovery and drug screening, as well as preclinical testing and precision medicine.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据